Evidence map›Paper›PMID 27624324›Full record

ArticleWiener klinische Wochenschrift2016

Metachronous gallbladder metastasis from renal cell carcinoma-a rare clinical manifestation.

Karl Mrak, Carolin Lackner, Hans-Jörg Mischinger, Peter Kornprat

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Uncommon site of metastasis from renal cell carcinoma: Case report.International journal of surgery case reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karl MrakDepartment of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria. Karl.Mrak@Klinikum-Graz.At.
Carolin LacknerInstitute of Pathology, Medical University Of Graz, Graz, Austria.
Hans-Jörg MischingerDepartment of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria.
Peter KornpratDepartment of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria.
Medical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) represents a rare tumor entity accounting for approximately 3 % of all malignancies in the adult population. Approximately 30 % of all patients suffering from RCC develop metastases after nephrectomy and another 30 % of patients suffer from synchronous metastases at the date of diagnosis. Gallbladder metastases represent an extremely rare clinical condition and up to date there are only 35 published cases of gallbladder metastasis from RCC. Surgical resection should be the treatment of choice in any case based on the reported data in literature. In spite of the small series of cases, survival can be improved even in patients suffering from additional sites of metastases.

Indexed as

AgedCarcinoma, Renal CellGallbladder NeoplasmsHumansKidney NeoplasmsMaleNeoplasms, Second PrimaryRare DiseasesTreatment OutcomeGallbladderMetachronous neoplasmsNeoplasm metastasesRenal cell carcinomaTherapeutics

Identifiers

PMID27624324
OpenAlexW2518965321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.